برادران، مجید؛ زارع، حسین؛ علیپور، احمد؛ فرزاد، ولیالله. (1395). اثربخشیدرمانمبتنیبرتعهدوپذیرش برهمجوشیشناختیوشاخصهایسلامت جسمانیبیمارانمبتلابهفشارخوناساسی.
فصلنامه روانشناسی شناختی، 4(1-2): 9-1.
]پیوند[
ثناگویمحرر، غلامرضا؛ حسین زاده، محدثه. (1396). بررسیرابطهخودتنظیمیهیجانیباتحملپریشانیوکیفیتزندگیانجمنبیماریام اس (مطالعهموردیبیماراناماساستانسیستانوبلوچستان).
فصلنامه مطالعات علوم اجتماعی، 3(2): 203-196.
]پیوند[
شاکرنژاد، سپیده؛ نسرین، موذن؛ حمیدی، معصومه؛ هاشمی، رها؛ بزاززاده، نیلوفر؛ بداقی، مظاهر. (1396). اثربخشیدرمانمبتنیبرپذیرشوتعهدبرپریشانیروانشناختی،رضایت زناشوییوکیفیتزندگیدرزنانمبتلابهبیماریاسکلروز متعدد.
مجله سلامت و مراقبت، 19(1): 17-8.
]پیوند[
شیدایی اقدم، شوان؛ شمس الدینی لری، سلوی؛ عباسی، سمیه؛ یوسفی، سارا؛ عبداللهی، صفیه؛ مرادی جو، محمد. (1393). اثربخشیدرمانمبتنیبر پذیرشوتعهدبرکاهشپریشانی ونگرشهایناکارآمددربیمارانمبتلابه
.M.S
اندیشه و رفتار، 9(34): 66-57.
]پیوند[
میرزمانی، سید محمود؛ صفری، اکبر؛ حلی ساز، محمد تقی؛ سدیدی، احمد. (1386). ارزیابیاعتبارپرسشنامهچندبعدیدردوستهاون
-ییلدربینبیمارانمبتلابهدردمزمن.
مجله دانشگاه علوم پزشکی قم، 1(3): 25-13.
]پیوند[
نیکوگفتار،منصوره؛خانعلیلو،رویا. (1396). مقایسهاثربخشیدرمانشناختیرفتاریودرمانمبتنیبرپذیرشوتعهدبرکاهشنشانههایافسردگیبیمارانزنمبتلا
به Multiple Sclerosis (MS)
.مجلهتحقیقاتعلومرفتاری، 15(1): 66-59.
]پیوند[
Bennett, R., & Oliver, J. E. (2019). Acceptance and Commitment Therapy: 100 Key Points and Techniques. Routledge.
Broglio, S. P., Kontos, A. P., Levin, H., Schneider, K., Wilde, E. A., Cantu, R. C., ... & Giza, C. (2018). National Institute of neurological disorders and stroke and department of defense sport-related concussion common data elements version 1.0 recommendations.
Journal of Neurotrauma, 35(23), 2776-2783. [
Link]
Burkill, S., Montgomery, S., Kockum, I., Piehl, F., Strid, P., Hillert, J., & Bahmanyar, S. (2019). The association between multiple sclerosis and pain medications.
Pain, 160(2), 424-432. [
Link]
Craig, A.W. (2001). Cognitive behaviour therapy for chronic medical problems: a guide to assessment and treatment in practice. 1st ed. Wiley.
De Oliveira, J.F., Wiener, C.D., Jansen, K., Portela, L.V., Lara, D.R., de Mattos Souza, L.D., da Silva, R.A., Moreira, F.P., & Oses, J.P. (2018). Serum levels of interleukins IL-6 and IL-10 in individuals with posttraumatic stress disorder in a population-based sample.
Psychiatry Research, 260, 111-115. [
Link]
Del Vecchio, M., Bajetta, E., Canova, S., Lotze, M. T., Wesa, A., Parmiani, G., & Anichini, A. (2007). Interleukin-12: biological properties and clinical application.
Clinical Cancer Research, 13(16), 4677-4685. [
Link]
Dennison, L., Moss-Morris, R., & Chalder, T. (2009). A review of psychological correlates of adjustment in patients with multiple sclerosis.
Clinical Psychology Review, 29(2), 141-153. [
Link]
Gardner, C. M. (2018).
Exploring the effects of Acceptance and Commitment Therapy (ACT) on biomarkers of stress in breast cancer survivors (Doctoral dissertation, University of Southern Queensland). [
Link]
Greeson, J. M. (2009). Mindfulness research update: 2008.
Complementary Health Practice Review, 14(1), 10-18. [
Link]
Hann, K. E., & McCracken, L. M. (2014). A systematic review of randomized controlled trials of Acceptance and Commitment Therapy for adults with chronic pain: Outcome domains, design quality, and efficacy.
Journal of Contextual Behavioral Science, 3(4), 217-227. [
Link]
Harris, R. (2009). ACT Made Simple: An Easy-To-Read Primer on Acceptance and Commitment Therapy. Oakland, CA: New Harbinger.
Harrison, A. M., McCracken, L. M., Jones, K., Norton, S., & Moss-Morris, R. (2017). Using mixed methods case-series evaluation in the development of a guided self-management hybrid CBT and ACT intervention for multiple sclerosis pain.
Disability and Rehabilitation, 39(18), 1785-1798. [
Link]
Hayes, S. C. (2008). Climbing our hills: A beginning conversation on the comparison of acceptance and commitment therapy and traditional cognitive behavioral therapy.
Clinical Psychology: Science and Practice, 15(4), 286-295. [
Link]
Hayes, S. C. (2019). Acceptance and commitment therapy: towards a unified model of behavior change.
World Psychiatry, 18(2), 226-227. [
Link]
Hayes, S. C., Luoma, J., Bond, F., Masuda, A., & Lillis, J. (2006). Acceptance and Commitment Therapy: Model, processes, and outcomes.
Behavior Research and Therapy, 44(1), 1-25. [
Link]
Heesen, Ch., Sieverding, F., Schoser, B. G. H., Hadji, B., & Kunze, K. (1999). Interleukin‐12 is detectable in sera of patients with multiple sclerosis—association with chronic progressive disease course?
European Journal of Neurology, 6(5), 591-596. [
Link]
Järvelä-Reijonen, E., Puttonen, S., Karhunen, L., Sairanen, E., Laitinen, J., Kolehmainen, M. & Lappalainen, R. (2020). The Effects of Acceptance and Commitment Therapy (ACT) Intervention on Inflammation and Stress Biomarkers: a Randomized Controlled Trial.
International Journal of Behavioral Medicine, 1-17. [
Link]
Kahraman, T., Özdoğar, A. T., Ertekin, Ö. & Özakbaş, S. (2019). Frequency, type, distribution of pain and related factors in persons with multiple sclerosis.
Multiple Sclerosis and Related Disorders, 28, 221-225. [
Link]
Kangas, M., & McDonald, S. (2011). Is it time to act? The potential of acceptance and commitment therapy for psychological problems following acquired brain injury.
Neuropsychological Rehabilitation, 21(2), 250-276. [
Link]
Kashdan, T. B., & Rottenberg, J. (2010). Psychological flexibility as a fundamental aspect of health.
Clinical Psychology Review, 30 (7), 865-878. [
Link]
Kerns, R.D., Turk, D.C., Rudy, T.E. (1985). The west haven-yale multidimensional pain inventory (WHYMPI).
Pain. 23: 345-356. [
Link]
Kim, Y. K., Suh, I. B., Kim, H., Han, C. S., Lim, C. S., Choi, S. H., & Licinio, J. (2002). The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
Molecular Psychiatry, 7(10), 1107. [
Link]
Losy, J., & Michałowska‐Wender, G. (2002). In vivo effect of interferon‐β 1a on interleukin‐12 and TGF‐β1 cytokines in patients with relapsing–remitting multiple sclerosis.
Acta Neurologica Scandinavica, 106(1), 44-46. [
Link]
Martin, K. J. (2018).
Effectiveness of Acceptance and Commitment Therapy self-help for carers of people with multiple sclerosis: A feasibility randomised controlled trial (Doctoral dissertation, University of Nottingham). [
Link]
Melzack, R., & Wall, P. D. (2016). Interaction of fast and slow conducting fibre systems involved in pain and analgesia. Proc. 3rd Int. Pharm. Meet, 9, 231-242.
Murray, E.D., Buttner, E.A., Price, B.H. (2012). Depression and Psychosis in Neurological Practice. In Daroff R, Fenichel G, Jankovic J, Mazziotta J. Bradley's neurology in clinical practice (6th ed.). Philadelphia, PA: Elsevier/Saunders.
Özenci, V., Pashenkov, M., Kouwenhoven, M., Rinaldi, L., Söderström, M., & Link, H. (2001). IL-12/IL-12R system in multiple sclerosis.
Journal of Neuroimmunology, 114(1), 242-252. [
Link]
Pakenham, K. I., Scott, T., & Uccelli, M. M. (2018).Short Report: Evaluation of Acceptance and Commitment Therapy Training for Psychologists Working with People with Multiple Sclerosis
. International Journal of MS Care, 20(1), 44-48. [
Link]
Sheppard, S. C., Forsyth, J. P., Hickling, E. J., & Bianchi, J. (2010). A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis: Results from a half-day workshop intervention.
International Journal of MS Care, 12(4), 200-206. [
Link]
Simons, J. S & Gaher, R.M. (2005). The distress tolerance scale: Development & validation of a self report measure.
Motivation & Emotion, 20(9), 83- 102. [
Link]
Song, C., Li, X., Leonard, B. E., & Horrobin, D. F. (2003). Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats.
Journal of Lipid Research, 44(10), 1984-1991. [
Link]
Sun, L., He, C., Nair, L., Yeung, J., & Egwuagu, C. E. (2015). Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
Cytokine, 75(2), 249-255. [
Link]
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., & Fujihara, K. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
The Lancet Neurology, 17(2), 162-173. [
Link]
Trinchieri, G. (1993). Interleukin-12 and its role in the generation of TH1 cells.
Immunology Today, 14(7), 335-338. [
Link]
Trinchieri, G., & Scott, P. (1994). The role of interleukin 12 in the immune response, disease and therapy.
Immunology Today, 15(10), 460-463. [
Link]
Van Boxel-Dezaire, A. H. H., van Trigt-Hoff, S. C. J., Killestein, J., Schrijver, H. M., Van Houwelingen, J. C., Polman, C. H., & Nagelkerken, L. (2000). Contrasting responses to interferon β-1 b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?
Annals of Neurology, 48(3), 313-322. [
Link]
Wetherell, J. L., Afari, N., Rutledge, T., Sorrell, J. T., Stoddard, J. A., Petkus, A. J., & Atkinson, J. H. (2011). A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain.
Pain, 152(9), 2098-2107. [
Link]
Zhang, M., Li, X., Li, J., Sun, H., Zhang, X., & Bao, J. (2017). Effects of confinement on physiological and psychological responses and expression of interleukin 6 and brain derived neurotrophic factor mRNA in primiparous and multiparous weaning sows.
Asian-Australasian Journal of Animal Sciences, 30(9), 1350. [
Link]